Revaprazan-loaded surface-modified solid dispersion: physicochemical characterization and in vivo evaluation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Jong Hyuck | - |
dc.contributor.author | Cho, Jung Hyun | - |
dc.contributor.author | Kim, Dong Shik | - |
dc.contributor.author | Kim, Jung Suk | - |
dc.contributor.author | Din, Fakhar Ud | - |
dc.contributor.author | Kim, Jong Oh | - |
dc.contributor.author | Yong, Chul Soon | - |
dc.contributor.author | Youn, Yu Seok | - |
dc.contributor.author | Oh, Kyung Taek | - |
dc.contributor.author | Kim, Dong Wuk | - |
dc.contributor.author | Choi, Han-Gon | - |
dc.date.accessioned | 2021-06-22T10:00:54Z | - |
dc.date.available | 2021-06-22T10:00:54Z | - |
dc.date.created | 2021-01-21 | - |
dc.date.issued | 2019-07 | - |
dc.identifier.issn | 1083-7450 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/2759 | - |
dc.description.abstract | The purpose of this research was to develop a novel revaprazan-loaded surface-modified solid dispersion (SMSD) with improved drug solubility and oral bioavailability. The impact of carriers on aqueous solubility of revaprazan was investigated. HPMC and Cremophor A25 were selected as an appropriate polymer and surfactant, respectively, due to their high drug solubility. Numerous SMSDs were prepared with various concentrations of carriers, using distilled water, and the drug solubility of each was assessed. Moreover, the physicochemical properties, dissolution and pharmacokinetics of selected SMSD in rats were assessed in comparison to revaprazan powder. Of the SMSDs assessed, the SMSD composed of revaprazan/HPMC/Cremophor A25 at the weight ratio of 1:0.28:1.12 had the most enhanced drug solubility (approximate to 6000-fold). It was characterized by particles with a relatively rough surface, suggesting that the carriers were attached onto the surface of the unchanged crystalline revaprazan powder. It had a significantly higher dissolution rate, AUC and C-max, and a faster T-max value in comparison to revaprazan powder, with a 5.3-fold improvement in oral bioavailability of revaprazan. Therefore, from an environmental perspective, this SMSD system prepared with water, and without organic solvents, should be recommended as a revaprazan-loaded oral pharmaceutical alternative. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | TAYLOR & FRANCIS LTD | - |
dc.title | Revaprazan-loaded surface-modified solid dispersion: physicochemical characterization and in vivo evaluation | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Han-Gon | - |
dc.identifier.doi | 10.1080/10837450.2019.1597114 | - |
dc.identifier.scopusid | 2-s2.0-85065082413 | - |
dc.identifier.wosid | 000468538200013 | - |
dc.identifier.bibliographicCitation | PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, v.24, no.6, pp.788 - 793 | - |
dc.relation.isPartOf | PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY | - |
dc.citation.title | PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY | - |
dc.citation.volume | 24 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 788 | - |
dc.citation.endPage | 793 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | ORAL BIOAVAILABILITY | - |
dc.subject.keywordPlus | ENHANCED SOLUBILITY | - |
dc.subject.keywordPlus | FENOFIBRATE | - |
dc.subject.keywordPlus | ABSORPTION | - |
dc.subject.keywordPlus | MICROCAPSULES | - |
dc.subject.keywordPlus | STABILITY | - |
dc.subject.keywordAuthor | Revaprazan | - |
dc.subject.keywordAuthor | surface-modified solid dispersion | - |
dc.subject.keywordAuthor | unchanged crystalline | - |
dc.subject.keywordAuthor | drug solubility | - |
dc.subject.keywordAuthor | oral bioavailability | - |
dc.identifier.url | https://www.tandfonline.com/doi/full/10.1080/10837450.2019.1597114 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.